Skip to content
prognos-logo-light Prognos Health
Main Menu
  • Support
  • Client Login
  • Request Demo
  • prognosFACTOR®
    • Marketplace
  • Products
    • Life Sciences
      • Cohort Designer
      • Patient Journey
      • Physician Segmentation
      • Outcomes
      • Alerts
      • Omnichannel Marketing
    • Payers
      • Underwriting Risk Predictor
      • Risk Adjustment & Quality Analytics
  • Company
    • Careers
    • Events
    • News
    • Insights
  • Contact Us
Home Insights Deterministic or predictive profiles? How to optimize your HCP promotional activities across channels

Deterministic or predictive profiles? How to optimize your HCP promotional activities across channels

  • June 6, 2019
  • Posted in Omnichannel Marketing

This post was last updated on December 29, 2020 at 12:52 pm

Icons over high speed design

We’re excited to share part three of our blog series about one of the most promising  methodologies for life science brands to harness: real world clinical diagnostics data to power HCP omni-channel marketing. We’ve broken up our series into five tranches to explore how early adopters are synchronizing all promotion activity based on clinical diagnostic insights for competitive advantage. If you missed the kick-off blog, check it out here!

Once clinical data sources are harmonized into one central engine to segment at the patient level and link to the treating HCP, life science marketers have two core paths to generate clinical profiles that match a brand’s indications.

Path One: Deterministic – The attributes from your clinical data sources can be queried with exact boolean logic phrases that can be matched to your therapy’s indication.

  • Example: Show me all patients who had an uncontrolled A1c score above 7.5 and currently on a second  line therapy this week?

Clinical diagnostic insight firms like Prognos have these exact attributes to write this rule and then link to the treating HCP. This deterministic profile (segment), could give marketers  the insights required to deliver relevant branded or unbranded messages at the right time.

Path Two: Predictive – The attributes of a longitudinal clinical data source(s) can be harnessed as a training dataset to set up predictive experiments.

  • Example: Show me all patients who are currently on a second line therapy for diabetes and will probabilistically move to a third line therapy one month from now?

Since scalable firms like Prognos have the deterministic data historically, the same deterministic dataset can be used to train a forward looking model to predict when a patient will more than likely require a third line therapy. Again, another tactic to help intervene at the right time.

There’s no direct answer to which path to choose. All depends on the use case and the outcomes a life science marketer is seeking to achieve. Focus on outcomes first, then work your way backwards to the best solution.

Traditionally, the majority of HCP segmentation has been designed from a deterministic perspective. Clinician-based rules that are specifically aligned to the brand’s indications. Coupled with a scalable registry or clinical information, this is an exceptional  solution. Brands and entire portfolios can design multiple profiles that link by indication, by creative message, and by channel.

On the predictive side, life science firms are harnessing machine learning tools to predict when certain events may occur, such as below:

Diagnosis of a certain disease —> Treatment start or change —> Disease progression

Prognos, for instance, works with many rare disease therapeutics. A big challenge in this market is diagnosis. Bringing awareness to the disease and/or ensuring HCPs are aware of certain lab testing to treat patients is paramount.

Disease progression is another use case for applying machine learning to your diagnostic datasets. Below is an example of a third line therapy progression.

The goal of this therapy was to predict three-months in advance prior treatment change. As in all data experiments, probabilistic scores are generated (nothing is 100% in the predictive world!). But that’s ok, when this use case makes sense life science marketers can allocate reach and efficiency by marketing channel. The least efficient segment (4.6% in this example), send to your programmatic digital advertising HCP media channel. You’d want to send a higher scoring segment to your field force (the cost of people is much more expensive than sending a couple digital ads to those HCPs!).

Contact us for more information and share your omnichannel strategy with our experts.

About the Author: Matt Apprendi has been a fixture in the NYC technology scene for more than a decade, where he’s focused on conceptualizing, building and commercializing intelligent data products. As VP of Digital Solutions at Prognos, Matt is responsible for unlocking the value of clinical diagnostic data to power intelligent digital applications across the greater healthcare ecosystem.

« What to Consider if Your Drug is a Targeted Therapy for a New Biomarker
In the Fight Against Prostate Cancer, Every Month Is Men’s Health Month »

Categories

  • AI
  • Alerts
  • Clinical
  • Commercial Launch Excellence
  • Disease Awareness
  • Lab Testing Insights
  • Lab Testing Trends
  • Omnichannel Marketing
  • Physician Segmentation
  • Prog Spotlight
  • Technology

Archives

Latest Tweets

Prognos HealthFollow

Prognos Health
prognosAIPrognos Health@prognosAI·
19 Feb

#HealthcareAnalytics are evolving.

On Tuesday February 23, Prognos Health co-founder and CEO, @sundeepbhan, will join @Safeguard for a virtual discussion on the healthcare data revolution with @GKurtzman.

Register: https://us02web.zoom.us/webinar/register/WN_WlCiq5v2TICwSMRi-PVGZw

#HealthcareData #prognosFACTOR

Reply on Twitter 1362875761674354689Retweet on Twitter 1362875761674354689Like on Twitter 1362875761674354689Twitter 1362875761674354689
prognosAIPrognos Health@prognosAI·
11 Feb

Find a way, or make a way. It’s the Prognos mantra embraced by Ali Koc, VP of Engineering at Prognos Health.

In his latest blog post, Ali writes about making data accessible at web speeds, and how it enables data analysis in a truly new way.

https://prognoshealth.com/blog/find-a-way-or-make-a-way-building-an-interactive-analytics-platform-that-speaks-healthcare/

#HealthTech

Reply on Twitter 1359933724088020994Retweet on Twitter 1359933724088020994Like on Twitter 13599337240880209942Twitter 1359933724088020994
prognosAIPrognos Health@prognosAI·
28 Jan

#TBT to our webinar featuring #LifeSciences thought leaders from @Novartis, @TakedaPharma, and @pfizer as well as Prognos Co-founder @jmbhan.

Our latest blog explores 9 insights from these experts for driving #Commercial #LaunchExcellence in #Pharma

https://prognoshealth.com/blog/overheard-at-the-reuters-health-webinar-9-insights-for-driving-commercial-launch-excellence/

Reply on Twitter 1354901342679146499Retweet on Twitter 1354901342679146499Like on Twitter 13549013426791464991Twitter 1354901342679146499
prognosAIPrognos Health@prognosAI·
22 Jan

Uncovering the (Clinical) Truth.

Bill Bowman and @olatulekan write about the intersection where #MachineLearning meets disease-specific #clinical knowledge - #ClinicalTruths - and how this improves #PatientOutcomes with #HealthcareAnalytics at scale.

https://prognoshealth.com/blog/uncovering-the-clinical-truth/

Reply on Twitter 1352709796135391237Retweet on Twitter 13527097961353912371Like on Twitter 13527097961353912373Twitter 1352709796135391237
prognosAIPrognos Health@prognosAI·
31 Dec

As we ring in the new year, there's so much to look forward to. We wish all of our clients, and partners a healthy, happy new year and are excited to continue innovating together in 2021 to positively impact care.

Reply on Twitter 1344647644669468672Retweet on Twitter 1344647644669468672Like on Twitter 13446476446694686722Twitter 1344647644669468672
Load More...
  • prognosFACTOR®
    • Marketplace
  • Products
    • Life Sciences
    • Payers
  • Company
    • Insights
    • Careers
    • Events
    • News
  • LinkedIn
  • Twitter
  • YouTube
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Site Map
© Prognos Health, 2021. All Rights Reserved.

See What Decision Speed Looks Like in Action

To give you the best possible experience, this site uses cookies and by continuing to use the site you agree that we can save them on your device. For more details about cookies and their use, please see our Privacy Policy.